BETTARI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 877
EU - Europa 844
AS - Asia 177
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.902
Nazione #
US - Stati Uniti d'America 875
PL - Polonia 490
CN - Cina 111
RU - Federazione Russa 110
UA - Ucraina 95
DE - Germania 34
FI - Finlandia 34
IT - Italia 33
HK - Hong Kong 22
VN - Vietnam 20
GB - Regno Unito 17
IN - India 16
IE - Irlanda 13
FR - Francia 6
BE - Belgio 4
SE - Svezia 4
SG - Singapore 3
TR - Turchia 3
BR - Brasile 2
CA - Canada 2
EU - Europa 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
IR - Iran 1
LV - Lettonia 1
NL - Olanda 1
SA - Arabia Saudita 1
Totale 1.902
Città #
Warsaw 490
Fairfield 131
Moscow 110
Woodbridge 86
Ann Arbor 75
Ashburn 71
Jacksonville 71
Chandler 67
Houston 66
Seattle 63
Cambridge 57
Wilmington 48
Princeton 30
Beijing 27
Nanjing 26
Hong Kong 22
Helsinki 21
Dong Ket 20
Dublin 13
New York 13
Nanchang 12
Dearborn 8
Pune 8
Tianjin 8
Changsha 7
Des Moines 7
San Diego 7
Brescia 6
Milan 6
Palermo 6
Shanghai 6
Shenyang 5
Brussels 4
Hebei 4
Los Angeles 4
Phoenix 4
Hangzhou 3
Jiaxing 3
London 3
Verona 3
Florence 2
Indiana 2
Jinan 2
Kocaeli 2
Lancaster 2
Ningbo 2
Ruvo Di Puglia 2
Taiyuan 2
Altopascio 1
Amsterdam 1
Ardabil 1
Boardman 1
Corsico 1
Hanover 1
Kunming 1
Langley 1
Mumbai 1
Noto 1
Reston 1
Riyadh 1
Rome 1
San Francisco 1
Shaoxing 1
Singapore 1
São Paulo 1
Taizhou 1
Toronto 1
Totale 1.656
Nome #
Can we improve the treatment of congestion in heart failure? 211
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 210
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 206
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 200
Old and new intravenous inotropic agents in the treatment of advanced heart failure 200
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 153
Neurohormonal activation in acute heart failure: results from VERITAS 107
Can we prevent or treat renal dysfunction in acute heart failure? 104
Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. 96
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 93
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? 89
Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions 78
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 66
La terapia con inotropi del paziente con insufficienza cardiaca: oltre i farmaci tradizionali 56
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 48
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 12
Totale 1.929
Categoria #
all - tutte 6.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201999 0 0 0 0 0 0 0 0 0 0 54 45
2019/2020587 58 36 33 63 45 66 48 60 50 57 38 33
2020/2021343 15 37 11 50 18 33 25 36 42 26 23 27
2021/2022142 11 31 0 3 4 9 11 7 5 21 12 28
2022/2023140 15 4 3 11 24 31 0 24 13 0 9 6
2023/2024230 14 5 7 17 10 31 2 6 24 105 9 0
Totale 1.929